Article Details
Retrieved on: 2022-08-22 08:38:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Some of the therapeutic options are monoclonal antibodies against VEGF or VEGFR, soluble VEGF and VEGFR hybrids and tyrosine kinase inhibitors.
Article found on: www.fmiblog.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here